This study is for cancer patients who smoke and have not wanted to try traditional ways to quit. It aims to see if switching completely from regular cigarettes to e-cigarettes (Harm Reduction) can help reduce the harm from smoking. You would either be given an e-cigarette to try and switch, or you would receive information about other tobacco treatment programs (Standard of Care). The main goal is to see how many people in each group completely switch from smoking to e-cigarettes after 6 months. To join, you must be at least 21 years old, currently smoke, have refused traditional tobacco treatment, and speak English. The study is currently unclear about its recruitment status.

Study design

This study is an interventional trial comparing two groups: one using e-cigarettes and another receiving standard care. It plans to enroll 208 participants.

What's involved

You would complete baseline assessments, including a breath CO test and a blood draw for biomarker assessment. The primary endpoint for measuring complete switching is at 6 months.

Compensation

Not stated in the trial record.

Follow-up

The main goal of the study is measured at 6 months, which suggests follow-up for at least that duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.